The Maudsley Prescribing Guidelines in Psychiatry

The Maudsley Prescribing Guidelines in Psychiatry

Edited by Dr. David Taylor , Edited by Dr. Carol Paton , Edited by Dr. Shitij Kapur

US$85.24

Free delivery worldwide

Available
Dispatched in 1 business day

When will my order arrive?

Helps with complex prescribing needs The evidence base for drug treatments in psychiatry ranges frommeta-analyses and randomised controlled clinical trials tosingle case reports, and from NICE guidelines to individualSPCs. Where do you look for information when transferring apatient from one drug to another? Where do you find a clearoverview when dealing with a complex patient (e.g, with co-morbidepilepsy or liver disease or HIV infection)? Where canyou seek advice on prescribing psychotropics duringpregnancy? The Maudsley Prescribing Guidelines inPsychiatry! The leading clinical reference for handlingprescribing problems as encountered in daily practice and forformulating prescribing policy. Evidence-based and written by experts This book is the essential guide for anyone responsible forprescribing, dispensing or administering drugs for patients withmental health disorders. All the evidence has been reviewedand summarized succinctly by an expert team of psychiatrists andpharmacists. New content and improved format This new edition makes greater use of tables and boxes tofacilitate quick reference and includes new sections oncytochrome-mediated interactions and psychiatric side effects ofnon-psychotropic drugs. Clinically relevant Chapters address plasma monitoring, schizophrenia, bipolardisorder, depression and anxiety, children and adolescents,substance abuse and special patient groups. Each section hasa full reference list. The book covers prescribing drugsoutside their licensed indications and their interaction withsubstances such as alcohol, nicotine and caffeine. Useful for all levels of experience Trainees will gain important information regarding the rational,safe and effective use of medications for patients with mentalillness. Experienced clinicians will find excellent guidanceregarding more complex issues that they may not encounterregularly. Why the Maudsley Prescribing Guidelines inPsychiatry? Long recognized as an international trailblazer in mental healthcare, the Maudsley Hospital earned its reputation for excellence inboth in-patient and community care. It is highly regarded forits research, and pioneered the use of clinical neuroscience. Youcan trust The Maudsley Prescribing Guidelines in Psychiatryto be scientifically sound and clinically effective.

show more
  • Paperback | 680 pages
  • 167.64 x 218.44 x 27.94mm | 1,020.58g
  • 24 Apr 2012
  • John Wiley and Sons Ltd
  • Wiley-Blackwell (an imprint of John Wiley & Sons Ltd)
  • Chicester
  • English
  • Revised
  • 11th Revised edition
  • 0470979488
  • 9780470979488
  • 14,469

Other books in this category

Other people who viewed this bought:

Author Information

David Taylor is Director of Pharmacy and Pathology at theSouth London and Maudsley NHS Foundation Trust, and Professor ofPsychopharmacology at King s College London. The leadauthor of all editions of the Maudsley PrescribingGuidelines, Professor Taylor is the author of several othertexts and editor of Therapeutic Advances inPsychopharmacology. Carol Paton is Chief Pharmacist at Oxleas NHS FoundationTrust, London: she is also joint Head of the PrescribingObservatory for Mental Health and an Honorary Research Fellow atImperial College London. Shitij Kapur is Professor of Schizophrenia, Imaging andTherapeutics and the Dean and Head of School at the Institute ofPsychiatry, King's College London.

show more

Review quote

This comprehensive guide presents clinicians withevidence-based information on prescribing psychotropic drugs formental health This book will help nurses to be confident,sensitive and informed when discussing medication with patients andrelatives, exploring treatment options within their professionalteams and liaising with allied health professionals. (Nursing Standard, 30 May 2012)

show more

Back cover copy

This book is the essential guide for anyone responsible for prescribing, dispensing or administering drugs for patients with mental health disorders. All the evidence has been reviewed and summarised succinctly by an expert team of psychiatrists and pharmacists. The evidence base for drug treatments in psychiatry ranges from meta-analyses and randomised controlled clinical trials to single case reports, from NICE guidelines to individual SPCs. Where to look for information when transferring a patient from one drug to another or when dealing with a complex patient (for example, with co-morbid epilepsy or liver disease or HIV infection)? "The Maudsley Prescribing Guidelines" are established as the leading clinical relevant reference for handling complex prescribing problems and for formulating prescribing policy. This new edition makes greater use of tables and boxes to facilitate quick reference and includes new sections on cytochrome-mediated interactions, psychiatric side effects of non-psychotropic drugs and on GBL and GHB dependence. Chapters cover plasma monitoring, schizophrenia, bipolar disorder, depression and anxiety, children and adolescents, substance misuse and special patient groups. Each section has a full reference list. The book covers prescribing drugs outside their licensed indications and their interaction with substances such as alcohol, nicotine and caffeine. Trainees will gain important information regarding the rational, safe and effective use of medications for patients with mental illness. Experienced clinicians will find excellent guidance regarding more complex issues that they may not encounter regularly. Praise for previous editions: "I would regard this book as mandatory for any pharmacist directly involved in the care of patients with a psychiatric diagnosis, be they primary or secondary care-based." "The Pharmaceutical Journal" "An excellent book and a 'must' for practising psychiatrists... not only will the rational prescribing of psychotropic drugs drastically improve but, more importantly, the patient will certainly benefit." "Human Psychopharmacology"

show more